Vallon Pharmaceuticals, Inc. announced that Leanne M. Kelly was appointed as an accounting officer of the company. In connection with Ms. Kelly’s appointment as principal financial and accounting officer, David Baker, who previously served as principal executive, financial and accounting officer, resigned as principal financial and accounting officer, but will continue to serve as the principal executive officer of the company.